Success Stories: EB-1A Approved for Translational Research and Molecular Pathology Researcher Advancing Cancer Biomarkers and microRNA-Guided Therapies following RFE

  Client’s Testimonial: “Thank you so much to all the attorneys and back-end team who helped me at various levels of filing and got it done positively in a short span of time as well.” On August 14th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Researcher in the field of Translational Research (Approval Notice). General Field: Translational Research Position at the Time of Case Filing: Researcher Country of Read more [...]